The value: why localisation pays off across global trials
June 26, 2026 | Localisation, clinical trials, translation
Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.
In our first two articles, we looked at where translation falls short and what good localisation actually looks like. Now we come to the part that affects timelines, budgets and trial delivery: the operational impact of getting localisation wrong.
Poor localisation rarely announces itself. It shows up quietly, in extra questions, slower processes, and avoidable rework. Strong localisation does the opposite. It keeps trials moving and helps sites focus on participants.
Where poor localisation creates friction
When materials don’t quite land, the effects ripple across sites and regions. Teams often see more site queries, with participants asking staff to explain content that should already be clear. Consent and onboarding slow down as confusion delays decisions. And when materials need revising market by market after launch, rework quickly builds.
These aren’t isolated problems. In our recent report The Site Factor, 27% of European respondents cited delays in receiving sponsor materials as their biggest barrier to enrolling participants. Just 24% of site teams say they use sponsor-provided materials, while others supplement them with their own materials or report having no participant-facing materials at all.
The hidden cost of fixing content late
Fixing localisation late is far more expensive than getting it right early. A single change to a master document can trigger updates across every language version, requiring fresh review, approval and redistribution. When amendments arrive out of sequence, sites are left unsure what to apply and when.
That uncertainty has a cost. It pulls site staff away from participants, adds review cycles, and risks inconsistency across regions. The later you spot the gap, the wider it spreads.
How strong localisation supports smoother delivery
Done well, localisation removes friction before it starts. Content arrives ready to use, reducing the burden on site teams to interpret, adapt or explain materials that participants find difficult to understand.
Across a trial, those benefits add up: fewer clarification queries for site staff, more consistent understanding across markets, smoother consent and onboarding processes, and less need for local workarounds or supplementary materials.
When participants understand what’s being asked of them, they’re more likely to engage and stay. And a better participant experience links directly to greater study completion.
Localisation, risk and diversity
Localisation isn’t just about clarity. It’s about reach. If your materials only work for some communities, your trial only reaches those communities. That limits diversity and skews representation, ultimately affecting the quality of the data generated.
Strong localisation helps you recruit fairly across regions and cultures. It reduces protocol misunderstandings, supports adherence, and lowers the risk of avoidable delays. In short, it makes trials more efficient and more representative.
Bringing the series together
Across these three articles, one idea has stayed constant. While translation carries the language, localisation carries the meaning.
That difference shapes how participants interpret, trust and engage with your trial. Treat localisation as a core part of your trial communication strategy, not a final production step, and you’ll see the value in smoother delivery, stronger engagement and better outcomes for everyone involved.
And that’s a goal worth building towards.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Cuttsy+Cuttsy welcomes new team members
Cuttsy+Cuttsy is excited to announce the addition of three talented professionals to the team: Flo, an enthusiastic Account Executive; Vicki, a creative Graphic Designer; and Jo, a detail-driven Artworker
Designing with patients in mind: How to build more inclusive clinical trials
Discover how patient-centred design transforms inclusive clinical trials. Learn to overcome trial recruitment challenges by listening to patients and creating studies that fit real lives.
Why fresh patient voices are critical to improve clinical trials outcomes
Discover why diverse patient voices, especially first-time participants, are key to improving clinical trials. Boost recruitment, retention, and patient-centric research.
Using patient personas to add a personal touch to clinical trial recruitment and retention
Discover how patient personas can revolutionise clinical trial recruitment and retention. Personalise outreach, build trust, and improve patient engagement.
A month of insights: Key takeaways from May’s conferences
Explore key insights from some of May’s top healthcare conferences, covering patient engagement, health equity, co-creation, and tech innovation shaping clinical trials.
Cuttsy+Cuttsy and ISPEP highlight key patient insights in new clinical trials report
Explore how Cuttsy+Cuttsy and ISPEP are spotlighting patient engagement in clinical trials through a new global report.
Motivations that matter: Understanding clinical trial participation to create better research
Understanding why people join clinical trials is essential to improving recruitment and designing better research. Explores the diverse motivations driving participation — from altruism and hope for better health to…
Cuttsy+Cuttsy welcomes new team members and celebrates a familiar face returning
Cuttsy+Cuttsy proudly announces the expansion of its team with the addition of three new hires—Michelle, Jay, and Emily—and the welcome return of former team member Sally as Account Director.
AI and away we go: key insights from Reuters Pharma 2025
AI is revolutionising the pharmaceutical industry, as highlighted at Reuters Pharma 2025, with transformative applications across marketing, drug discovery, and patient engagement, despite challenges in adoption, regulation, and data trust.
Exciting updates from our content and strategy team
Cuttsy+Cuttsy celebrates new beginnings with the appointment of Oli Bailey as Strategy Director and recognises team excellence through several well-deserved promotions.